Search results for "Palm"

showing 10 items of 338 documents

Partitioning of Pyrene-Labeled Phospho- and Sphingolipids between Ordered and Disordered Bilayer Domains

2004

AbstractHere we have studied how the length of the pyrene-labeled acyl chain (n) of a phosphatidylcholine, sphingomyelin, or galactosylceramide affects the partitioning of these lipids between 1), gel and fluid domains coexisting in bovine brain sphingomyelin (BB-SM) or BB-SM/spin-labeled phosphatidylcholine (PC) bilayers or 2), between liquid-disordered and liquid-ordered domains in BB-SM/spin-labeled PC/cholesterol bilayers. The partitioning behavior was deduced either from modeling of pyrene excimer/monomer ratio versus temperature plots, or from quenching of the pyrene monomer fluorescence by spin-labeled PC. New methods were developed to model excimer formation and pyrene lipid quenchi…

Macromolecular SubstancesMembrane FluidityLipid BilayersMolecular ConformationBiophysicsPhase Transition03 medical and health scienceschemistry.chemical_compoundMembrane MicrodomainsPhosphatidylcholineMembrane fluidityFluorometryLipid bilayerPhospholipids030304 developmental biologySphingolipids0303 health sciencesPyrenesMembranesQuenching (fluorescence)Staining and LabelingChemistry030302 biochemistry & molecular biologyTemperatureBiological membraneModels ChemicalBiochemistryDipalmitoylphosphatidylcholineLiposomesBiophysicsPyrenelipids (amino acids peptides and proteins)SphingomyelinBiophysical Journal
researchProduct

NEW SELF-ASSEMBLING POLYASPARTYLHYDRAZIDE COPOLYMER MICELLES FOR ANTICANCER DRUG DELIVERY.

2010

A new amphiphilic copolymer have been synthesized starting from the hydrosoluble polyaspartylhydrazide (PAHy) polymer, by grafting both hydrophilic PEG(2000) chains and hydrophobic palmitic acid (C(16)) moieties on polymer backbone, and the structure of obtained PAHy-PEG(2000)-C(16) copolymer have been characterized by 2D (1)H/(13)C NMR experiments. PAHy-PEG(2000)-C(16) copolymer showed the ability of self-assembling in aqueous media giving a core-shell structure and resulted potentially useful for encapsulating and dissolving hydrophobic drug. The formation of micellar core-shell structure has been investigated by 2D (1)H NMR NOESY experiments. The presence of cross-peaks for protons of C(…

Magnetic Resonance SpectroscopyLightCell SurvivalPolymersChemistry PharmaceuticalDrug CompoundingPalmitic AcidPharmaceutical ScienceAntineoplastic AgentsBreast NeoplasmsDRUG DELIVERY SELF ASSEMBLING POLYASPARTYLHYDRAZIDE MICELLES.MicelleFluorescencePolyethylene GlycolsDynamic light scatteringMicroscopy Electron TransmissionCell Line TumorAmphiphilePolymer chemistryCopolymerOrganic chemistryHumansNanotechnologyScattering RadiationTechnology PharmaceuticalSolubilityParticle SizeMicellesDrug CarriersDose-Response Relationship DrugChemistrytechnology industry and agricultureNuclear magnetic resonance spectroscopyHydrophobeTamoxifenSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoFemaleDrug carrierPeptidesHydrophobic and Hydrophilic Interactions
researchProduct

Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes.

2013

Polymeric micelles potentially able to carry to hepatocytes a ribavirin (RBV) prodrug, exploiting the presence of carbohydrate receptors, that is, ASGPR, were prepared starting from a galactosylated polylactide-polyaminoacid conjugate. This latter was obtained by chemical reaction of α,β-poly(N-2-hydroxyethyl) (2-aminoethylcarbamate)-dl-aspartamide (PHEA-EDA) with polylactic acid (PLA), and subsequent reaction with lactose, obtaining PHEA-EDA-PLA-GAL copolymer. To enhance the entrapment into obtained nanostructures, a hydrophobic RBV prodrug, that is, RBV tripalmitate, was synthesized and its capability to release RBV in the presence of an adequate enzymatic activity was demonstrated. Liver…

Magnetic Resonance SpectroscopyPolymers and PlasticsBioengineeringMicelleAntiviral AgentsBiomaterialschemistry.chemical_compoundNon-competitive inhibitionPolylactic acidRibavirinSpectroscopy Fourier Transform InfraredMaterials ChemistryCopolymerOrganic chemistryHumansProdrugsMicellesChemistrytechnology industry and agricultureGalactoseHep G2 CellsProdrugCarbohydrateCombinatorial chemistryIn vitroLiverSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoGalactosylated polymeric micelles hepatic cell-targeted carriers active targeting ribavirin tripalmitate hepatitis C.ConjugateBiomacromolecules
researchProduct

A moderate diet restriction during pregnancy alters the levels of endocannabinoids and endocannabinoid-related lipids in the hypothalamus, hippocampu…

2017

Existe para su consulta material suplementario aportado por el editor. Undernutrition during pregnancy has been associated to increased vulnerability to develop metabolic and behavior alterations later in life. The endocannabinoid system might play an important role in these processes. Therefore, we investigated the effects of a moderate maternal calorie-restricted diet on the levels of the endocannabinoid 2-arachidonoyl glycerol (2-AG), arachidonic acid (AA) and the N-acylethanolamines (NAEs) anandamide (AEA), oleoylethanolamide (OEA) and palmitoylethanolamide (PEA) in the brain of newborn rat offspring. We focused on brain structures involved in metabolism, feeding behavior, as well as em…

Male0301 basic medicineLitter (animal)Desnutrición:Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Olfactory Pathways::Olfactory Bulb [Medical Subject Headings]:Organisms::Eukaryota::Animals::Animal Population Groups::Animals Newborn [Medical Subject Headings]Ácido Araquidónicolcsh:MedicineHippocampusBiochemistry:Analytical Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Anthropometry::Body Weights and Measures::Body Size::Body Weight::Birth Weight [Medical Subject Headings]Oleoylethanolamidechemistry.chemical_compound0302 clinical medicinePregnancyMedicine and Health Sciences:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Rodentia::Muridae::Murinae::Rats::Rats Wistar [Medical Subject Headings]MasculinoPeso al nacerlcsh:Science:Phenomena and Processes::Reproductive and Urinary Physiological Phenomena::Reproductive Physiological Phenomena::Reproductive Physiological Processes::Reproduction::Pregnancy [Medical Subject Headings]MultidisciplinaryFemeninoBrainNeurochemistryPlantsLegumesLipidsOlfactory BulbEndocannabinoid systemEndocannabinoidesEncéfaloHypothalamusEmocionesFemalelipids (amino acids peptides and proteins)Restricción calóricaNeurochemicalsAnatomy:Diseases::Nutritional and Metabolic Diseases::Nutrition Disorders::Malnutrition [Medical Subject Headings]:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Arachidonic Acids [Medical Subject Headings]Research ArticleBulbo olfatoriomedicine.medical_specialtyEmbarazoAnimales recién nacidos:Phenomena and Processes::Physiological Phenomena::Nutritional Physiological Phenomena::Diet::Energy Intake::Caloric Restriction [Medical Subject Headings]OffspringHypothalamus:Check Tags::Male [Medical Subject Headings]Biology03 medical and health sciencesInternal medicineHipocampomedicineAnimals:Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hippocampus [Medical Subject Headings]:Chemicals and Drugs::Lipids::Fatty Acids::Endocannabinoids [Medical Subject Headings]Rats WistarCaloric RestrictionNutritionPregnancyPalmitoylethanolamideCognición:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Cognition [Medical Subject Headings]Ratas wistarlcsh:RMalnutritionOrganismsPeasBiology and Life Sciences:Anatomy::Nervous System::Central Nervous System::Brain [Medical Subject Headings]:Anatomy::Nervous System::Central Nervous System::Brain::Limbic System::Hypothalamus [Medical Subject Headings]Lipid Metabolismmedicine.diseaseRatsDietOlfactory bulb030104 developmental biologyEndocrinology:Check Tags::Female [Medical Subject Headings]Animals Newbornnervous systemchemistry:Psychiatry and Psychology::Behavior and Behavior Mechanisms::Emotions [Medical Subject Headings]lcsh:QHipotálamo030217 neurology & neurosurgeryEndocannabinoidsNeurosciencePLOS ONE
researchProduct

Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines…

2016

Palmitoylethanolamide (PEA) is an endogenous lipid mediator known to reduce pain and inflammation. However, only limited clinical studies have evaluated the effects of PEA in neuroinflammatory and neurodegenerative diseases. Multiple sclerosis (MS) is a chronic autoimmune and inflammatory disease of the central nervous system. Although subcutaneous administration of interferon (IFN)-β1a is approved as first-line therapy for the treatment of relapsing–remitting MS (RR-MS), its commonly reported adverse events (AEs) such as pain, myalgia, and erythema at the injection site, deeply affect the quality of life (QoL) of patients with MS. In this randomized, double-blind, placebo-controlled study,…

Male0301 basic medicinemyalgiaErythemaAnti-Inflammatory AgentsPalmitic AcidAdministration OralPharmacologyGastroenterologychemistry.chemical_compound0302 clinical medicineNeuroinflammationFAAHEthanolaminePharmacology (medical)SkinInterleukin-17food and beveragesAnti-Inflammatory AgentTolerabilityEthanolaminesDisease ProgressionCytokinesOriginal ArticleFemalemedicine.symptomInterferon beta-1aHumanAdultmedicine.medical_specialtyPainPalmitic AcidsProinflammatory cytokineInterferon-gamma03 medical and health sciencesMultiple Sclerosis Relapsing-RemittingDouble-Blind MethodInternal medicinemedicineHumansAdverse effectCytokinePharmacologyPalmitoylethanolamideExpanded Disability Status ScaleTumor Necrosis Factor-alphabusiness.industryMultiple sclerosisN-acylethanolamineOleoylethanolamideAnandamideNAAAmedicine.diseaseAmides030104 developmental biologychemistryNeurology (clinical)business030217 neurology & neurosurgeryNeurotherapeutics
researchProduct

Quantitative Acylcarnitine Profiling in Peripheral Blood Mononuclear Cells Using In Vitro Loading With Palmitic and 2-Oxoadipic Acids: Biochemical Co…

2005

Organic acid (OAD) and fatty acid oxidation disorders (FAOD) are inborn errors of metabolism often presenting with life-threatening metabolic decompensation followed by (irreversible) organ failure, and even death during catabolic state. Most of these diseases are considered as treatable, and metabolic decompensations can be avoided by early diagnosis and start of therapy. Confirmation of suspected diagnosis currently relies on enzymatic and mutation analyses and in vitro loading of palmitic acid in human skin fibroblast cultures. Furthermore, in some cases potentially life-threatening in vivo loading or fasting tests are still performed. In this study, we established a standardized in vitr…

MaleAdipatesPalmitic AcidPeripheral blood mononuclear cellMass SpectrometryMonocytesPalmitic acidBlood cellchemistry.chemical_compoundIn vivoCarnitinemedicineHumansChildBeta oxidationGlutaric aciduriaInfantMetabolismVenous bloodmedicine.anatomical_structurechemistryBiochemistryChild PreschoolPediatrics Perinatology and Child HealthFemaleMetabolism Inborn ErrorsPediatric Research
researchProduct

Loss of function mutation in the palmitoyl-transferase HHAT leads to syndromic 46,XY disorder of sex development by impeding Hedgehog protein palmito…

2014

The Hedgehog (Hh) family of secreted proteins act as morphogens to control embryonic patterning and development in a variety of organ systems. Post-translational covalent attachment of cholesterol and palmitate to Hh proteins are critical for multimerization and long range signaling potency. However, the biological impact of lipid modifications on Hh ligand distribution and signal reception in humans remains unclear. In the present study, we report a unique case of autosomal recessive syndromic 46,XY Disorder of Sex Development (DSD) with testicular dysgenesis and chondrodysplasia resulting from a homozygous G287V missense mutation in the hedgehog acyl-transferase (HHAT) gene. This mutation…

MaleCancer Research[SDV]Life Sciences [q-bio]medicine.disease_causeCell Fate DeterminationMiceTestisMorphogenesisMissense mutationddc:576.5Genetics (clinical)MutationHomozygoteCell DifferentiationHedgehog signaling pathwayPedigreeCell biologyFemaleSignal transductionSignal TransductionResearch Articlemedicine.medical_specialtylcsh:QH426-470LipoylationMolecular Sequence DataMutation MissenseBiologyPalmitoylationHHATInternal medicineGeneticsmedicineAnimalsHumansHedgehog ProteinsAmino Acid SequenceMolecular BiologyHedgehogEcology Evolution Behavior and SystematicsDisorder of Sex Development 46XY[ SDV ] Life Sciences [q-bio]Sequence Homology Amino AcidBiology and Life SciencesSex Determinationlcsh:GeneticsEndocrinology46 XY Disorders of Sex Development/*genetics; Acyltransferases/chemistry/*genetics/metabolism; Amino Acid Sequence; Animals; Female; Hedgehog Proteins/*metabolism; Homozygote; Humans; Lipoylation/*genetics; Male; Mice; Molecular Sequence Data; *Mutation Missense; Pedigree; Sequence Homology Amino Acid; Signal Transduction/*genetics; Testis/embryologyLipid modificationAcyltransferasesDevelopmental Biology
researchProduct

Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxid…

1988

Fischer-344 rats and Hartley guinea pigs received a diet containing 0.01% (w/w), 0.05% (w/w), or 0.25% (w/w) of the hypolipidemic drug fenofibrate. Rats were treated for 4, 7, 14, or 21 days, and a clear dose-dependent and weak time-dependent increase in liver/body weight ratio was observed. The specific activity of peroxisomal beta-oxidation increased linearly with time at all concentrations used. A dose-dependent increase in cEH was observed, but the activity remained constant after treatment for 7 days. Enhancement of palmitoyl-CoA hydrolase was dose-dependent, but was similar at all 4 time points investigated. In contrast to the other enzyme activities, mEH was not or only minimally (le…

MaleCancer Researchmedicine.medical_specialtyTime FactorsTiadenolGuinea PigsBiologyMicrobodiesGuinea pigCytosolInternal medicineMicrosomesHydrolasemedicineAnimalsHypolipidemic Agentschemistry.chemical_classificationEpoxide HydrolasesClofibrateFenofibrateGeneral MedicineRats Inbred F344RatsPalmitoyl-CoA hydrolaseEnzymeEndocrinologyOncologychemistryBiochemistryPalmitoyl-CoA HydrolaseMicrosomal epoxide hydrolaseEnzyme InductionThiolester Hydrolasesmedicine.drugJournal of cancer research and clinical oncology
researchProduct

Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia.

2008

The endocannabinoids anandamide (AEA) and palmitoylethanolamide (PEA) act as endogenous protective factors of the brain, using different pathways of neuroprotection against neuronal damage. Although several in vivo and in vitro studies confirmed the neuroprotective efficacy of endocannabinoids, no experimental settings compare and explore the neuroprotective potential of AEA and PEA in an acute stroke model. In this study, we investigated the neuroprotective potential by infarct measurement after high (30 mg/kg body weight) and low dosage administration (10 mg/kg body weight) of the endocannabinoid PEA in 49 male Wistar rats. In additions we studied infarct volumes of 22 male Wistar rats re…

MaleCannabinoid receptormedicine.medical_treatmentIschemiaPharmacologyNeuroprotectionBrain ischemiachemistry.chemical_compoundCannabinoid Receptor ModulatorsMedicineAnimalsRats WistarMolecular BiologyStrokePalmitoylethanolamidebusiness.industryGeneral NeuroscienceBrainRecovery of Functionmedicine.diseaseEndocannabinoid systemRatsNeuroprotective AgentschemistryIschemic Attack TransientAnesthesialipids (amino acids peptides and proteins)Neurology (clinical)CannabinoidbusinessDevelopmental BiologyEndocannabinoidsBrain research
researchProduct

Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat.

2004

The metabolic and genic effects induced by a 20-fold lowering of carnitine content in the heart were studied in mildronate-treated rats. In the perfused heart, the proportion of palmitate taken up then oxidized was 5-10% lower, while the triacylglycerol (TAG) formation was 100% greater than in controls. The treatment was shown to increase the maximal capacity of heart homogenates to oxidize palmitate, the mRNA level of carnitine palmitoyltransferase I (CPT-I) isoforms, the specific activity of CPT-I in subsarcolemmal mitochondria and the total carnitine content of isolated mitochondria. Concomitantly, the increased mRNA expression of lipoprotein lipase, fatty acid translocase and enzymes of…

MaleClinical BiochemistryPalmitic AcidBlood lipidsBiologyMitochondrionIn Vitro TechniquesMitochondria HeartOxygen ConsumptionCarnitinemedicineAnimalsCarnitineRNA MessengerRats WistarMolecular BiologyBeta oxidationHeart metabolismTriglycerideschemistry.chemical_classificationLipoprotein lipaseCarnitine O-PalmitoyltransferaseEsterificationMyocardiumFatty AcidsFatty acidBiological TransportCardiovascular AgentsCell BiologyGeneral MedicineRatsPerfusionLipoprotein LipasechemistryBiochemistryGene Expression RegulationCarnitine palmitoyltransferase IOxidation-Reductionmedicine.drugMethylhydrazinesMolecular and cellular biochemistry
researchProduct